Novelix Pharmaceuticals Ltd
Novelix Pharma. | 536565
Share Price Chart - Novelix Pharmaceuticals Ltd
Stock Performance
Ratios
About Company
- Novelix Pharmaceuticals Limited was initially incorporated as 'Trimurthi Securities Limited' on December 13, 1994
- The name of the Company was changed from Trimurthi Securities Limited to Trimurthi Drugs & Pharmaceuticals Limited
- Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Limited and again to Trimurthi Limited in May, 2016
- The Company has altered the name to Novelix Pharmaceuticals Limited in 2025
- Initially, the company was engaged in finance and investments in securities
- They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company
- Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification
- In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company
- In November 2009, the Company received NS-EN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from 'Kvalitet Veritas Quality Assurance'
- They had been appointed as Authorized Distributors on all India level for Livewell Food products and ABLE, Pharma, in the Salon District of Himachal Pradesh
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Novelix Pharmaceuticals Ltd?
The current share price of Novelix Pharmaceuticals Ltd (Novelix Pharma.) is ₹66.50. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Novelix Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Novelix Pharmaceuticals Ltd is 66.50. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd has a 52-week high of ₹92.00 and a 52-week low of ₹38.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Novelix Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Novelix Pharmaceuticals Ltd is ₹-0.87. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd has a Return on Equity (ROE) of 0.56%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
